2017-2019: DOCTORATE IN MOLECULAR GENETICS Inserm U1245, Genomics and Personalized Medecine in Cancer, Caen, FRANCE Main: improve the molecular diagnosis of hereditary breast and ovarian cancers (HBOCs) by the transcripts study of the predisposition genes.
2017-2018: MENTORING OF MASTER 1 TRAINEES Laboratoire de biologie et génétique du cancer, CLCC F. Baclesse, Caen, FRANCE
2018-2019: COURSES: UE INFORMATICS TOOLS IUT Génie Biologique, Caen, FRANCE 2017-2018: COURSES: UE – « OMICS » APPROACH Master 2 Mention Biologie Santé, Rouen, France 2017-2018: COURSES: UE STATISTICS TOOLS IUT Génie Biologique, Caen, FRANCE 2016: MASTER 2 IMMUNO-INFECTIOLOGY Inserm UE 966 MAVIVH, Tours, FRANCE
2015: MASTER 2 PHARMACOLOGIC MODELIZATION CNRS UMR 7292 GICC, Tours, FRANCE |
Pharmacokinetic and pharmacodynamics modelization of rituximab in children carriers idiopathic nephrotic syndrome, led by PhD David Ternant
In the area of “omics” approach, the expertise of next generation sequencing technology is a major challenge. Pharmacist graduate and thanks to my thesis works, I expanded my skills in the molecular biology, bioinformatics and biostatistics domain to operate on the data provided by these novel technologies. In reaching this mastery, I proved to be volunteer and motivate to achieve my goals. Then, I wish to value these achievements by continuing in the biomedical research in the frame of post-doctoral contract.